Psychosomatic features of anxiety and depressive disorders

Somatic symptoms of anxiety and depressive disorders are often encountered in patients presenting to primary care and general outpatient practices. The difficulty of diagnosing such conditions, the inconsistency of their severity with the diagnostic criteria of depressive or anxiety disorders requiring specialized psychiatric care, affect the quality of qualified medical care, increase health care costs, contribute to the chronicization of diseases, deterioration of quality of life and social functioning. An important problem is the safety and effectiveness of therapy of such conditions, preservation of trust in the doctor and the therapeutic process as a whole. The conducted study confirmed the clinical indications for Selank regulatory peptide and its efficacy in the therapy of not only anxiety states, unmotivated anxiety, mood instability, but also somatic manifestations of anxiety and depression, including asthenic, algic (back pain, stomach pain, headache, chest pain) symptom complexes, palpitations, nausea, feeling of weakness, fatigue, sleep disorders and recovery from psychoemotional stress